glp-1/gip receptor agonist The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Corrination of a GLP-1 Receptor
Description
Not everyone who desires a prescription treatment for weight loss qualifies for a GLP-1 agonist
The effects of dipeptidyl peptidase-4 inhibitors on bone fracture among patients with type 2 diabetes mellitus: a network meta-analysis of randomized controlled trials
Obsessed With: my family, my dog, my clients, loving life, and living it to the fullest!
10.1056/NEJMoa1612917 41 HusainM.BirkenfeldA
It complements but does not substitute for healthy lifestyle habits
